Exploring the Effects of HIV Drug Treatments on NASH Liver Disease
HIV drug treatments have transformed the landscape of HIV management, extending life expectancy and reducing mortality. However, as individuals with HIV age, liver health challenges, particularly metabolic dysfunction-associated steatotic liver disease (MASLD) and non-alcoholic steatohepatitis (NASH), have emerged. Delve into the intricate relationship between antiretroviral therapy and liver conditions, exploring management strategies and alternative treatment […]
3 minute read